International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2021   Volume 11   Issue 6

Comparison Study of COVID-19 Pandemic Scenario in Emerging Market and Regulatory Market
Download PDF


, , ,
Citation
Vancouver
Sahithi P, Thalla S, Koushik Y, Nadendla R. Comparison Study of COVID-19 Pandemic Scenario in Emerging Market and Regulatory Market. Int J Pharm Phytopharmacol Res. 2021;11(6):1-7. https://doi.org/10.51847/VNzEFxyYkz
APA
Sahithi, P., Thalla, S., Koushik, Y., & Nadendla, R. (2021). Comparison Study of COVID-19 Pandemic Scenario in Emerging Market and Regulatory Market. International Journal of Pharmaceutical And Phytopharmacological Research, 11(6), 1-7. https://doi.org/10.51847/VNzEFxyYkz
Download citation:   EndNote   RIS
Article Link:
Abstract

The corona virus (COVID-19) pandemic, a zoonotic disease transmitted from bat to human originated in Wuhan, China, has rapidly spread to several countries, with various cases having been reported globally. The second wave of the corona virus is spreading like a tsunami and is growing at an alarming rate compared to the first wave. It has been seen that the mutant virus is more transmissible and its incubation period is shorter. This article mainly deals with the number of people affected in the 1st and 2nd waves of COVID-19 in India and other countries. The study included all the cases reported from March 3, 2020 - August 31, 2021. The condition of the USA is even more critical than India, Brazil, Russia, United Kingdom, France, Turkey, Argentina, Italy, and other countries. The US has reported the highest number of cases (38,802,453) while Colombia has reported the lowest number of cases (4,905,258).

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

International Journal of Pharmaceutical and Phytopharmacological Research
© 2024 All rights reserved